Efficacy of Standard Prophylaxis Versus On-Demand Treatment With Bayer's Sucrose-Formulated Recombinant FVIII (rFVIII-FS) in Chinese Children With Severe Hemophilia A

Pediatric Hematology and Oncology - United Kingdom
doi 10.1080/08880018.2017.1313921

Related search